Non-steroidal anti-inflammatory drugs for relieving pain in musculoskeletal disorders
Pain control in musculoskeletal disorders is still a challenging task. The most effective treatment of pain in autoimmune and immune-mediated diseases is the treatment of the disease itself. Analgesics, non-steroidal anti-inflammatory drugs and opioids are used to relieve pain. Analgesia is the central intervention of degenerative disorders. The most effective analgesic compounds are the non-steroidal anti-inflammatory drugs (NSAIDs). Concerns are raised regarding the safety of NSAIDs. There is not any organ which is not involved in adverse reactions, but the damage of the gastrointestinal system has been considered the most serious one for a long time. In the 21st century, the recognition of cardiovascular complications led to the re-evaluation of the role of these drugs in analgesia. Orv Hetil. 2019; 160(22): 855-860.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:160 |
|---|---|
| Enthalten in: |
Orvosi hetilap - 160(2019), 22 vom: 10. Juni, Seite 855-860 |
| Sprache: |
Ungarisch |
|---|
| Weiterer Titel: |
Nemszteroid gyulladáscsökkentő szerek a mozgásszervi fájdalom csillapításában |
|---|
| Beteiligte Personen: |
Sütő, Gábor [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 05.11.2019 Date Revised 05.11.2019 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1556/650.2019.31502 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM297497057 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM297497057 | ||
| 003 | DE-627 | ||
| 005 | 20231225092123.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||hun c | ||
| 024 | 7 | |a 10.1556/650.2019.31502 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0991.xml |
| 035 | |a (DE-627)NLM297497057 | ||
| 035 | |a (NLM)31131611 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a hun | ||
| 100 | 1 | |a Sütő, Gábor |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Non-steroidal anti-inflammatory drugs for relieving pain in musculoskeletal disorders |
| 246 | 3 | 3 | |a Nemszteroid gyulladáscsökkentő szerek a mozgásszervi fájdalom csillapításában |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 05.11.2019 | ||
| 500 | |a Date Revised 05.11.2019 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Pain control in musculoskeletal disorders is still a challenging task. The most effective treatment of pain in autoimmune and immune-mediated diseases is the treatment of the disease itself. Analgesics, non-steroidal anti-inflammatory drugs and opioids are used to relieve pain. Analgesia is the central intervention of degenerative disorders. The most effective analgesic compounds are the non-steroidal anti-inflammatory drugs (NSAIDs). Concerns are raised regarding the safety of NSAIDs. There is not any organ which is not involved in adverse reactions, but the damage of the gastrointestinal system has been considered the most serious one for a long time. In the 21st century, the recognition of cardiovascular complications led to the re-evaluation of the role of these drugs in analgesia. Orv Hetil. 2019; 160(22): 855-860 | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a analgesia | |
| 650 | 4 | |a arthritis | |
| 650 | 4 | |a arthrosis | |
| 650 | 4 | |a fájdalom | |
| 650 | 4 | |a fájdalomcsillapítás | |
| 650 | 4 | |a nemszteroid gyulladáscsökkentő szerek | |
| 650 | 4 | |a non-steroidal anti-inflammatory drugs | |
| 650 | 4 | |a pain | |
| 650 | 7 | |a Analgesics |2 NLM | |
| 650 | 7 | |a Analgesics, Opioid |2 NLM | |
| 650 | 7 | |a Anti-Inflammatory Agents, Non-Steroidal |2 NLM | |
| 773 | 0 | 8 | |i Enthalten in |t Orvosi hetilap |d 1949 |g 160(2019), 22 vom: 10. Juni, Seite 855-860 |w (DE-627)NLM000021601 |x 1788-6120 |7 nnns |
| 773 | 1 | 8 | |g volume:160 |g year:2019 |g number:22 |g day:10 |g month:06 |g pages:855-860 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1556/650.2019.31502 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 160 |j 2019 |e 22 |b 10 |c 06 |h 855-860 | ||